Overview: Norovirus PCR TestIntroduction: The Norovirus PCR Test detects norovirus RNA to diagnose viral gastroenteritis, causing diarrhea or vomiting, helping guide treatment and infection control. Affecting 1 in 5 people annually, norovirus poses diagnostic challenges due to rapid spread. Following 2023 Centers for Disease Control and Prevention (CDC) guidelines, it uses RT-PCR for high accuracy, supporting virology screening. This test is vital for diagnosis, treatment planning, and improving outcomes in infectious disease.
Other Names: Norovirus RNA Test, Viral Gastroenteritis Assay.
FDA Status: FDA-approved test, meeting virology standards for diagnostic reliability.
Historical Milestone: Norovirus testing began in the 1990s with research by Green, who identified the virus. RT-PCR advancements in the 2000s by Qiagen improved detection, surpassing earlier electron microscopy methods.
Purpose: Detects norovirus RNA presence to diagnose gastroenteritis, guides supportive care, and evaluates patients with diarrhea, aiming to control outbreaks.
Test Parameters: Norovirus RNA presence
Pretest Condition: Fresh stool sample required. Collect stool. Report history of gastrointestinal symptoms.
Specimen: Stool (sterile container, 5-10 gm); Stool in sterile container. Transport in a biohazard container.
Sample Stability at Room Temperature: 4 hours
Sample Stability at Refrigeration: 24 hours
Sample Stability at Frozen: Not recommended
Medical History: Document diarrhea or vomiting. Include current medications or exposure history.
Consent: Written consent required, detailing the test's purpose, infection risks, and sample collection risks.
Procedural Considerations: Uses RT-PCR to detect RNA, requiring labs with thermal cyclers. Results available in 2-3 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample delay or contamination can affect results. Medications may not affect results but require correlation.
Clinical Significance: Positive RNA confirms norovirus, guiding care. Early isolation might prevent spread, while untreated cases lead to dehydration. Negative results may require other tests.
Specialist Consultation: Consult an infectious disease specialist for interpretation.
Additional Supporting Tests: Stool culture, electrolyte panel, or antigen test to confirm diagnosis.
Test Limitations: Specific to norovirus; correlation with symptoms needed. False negatives possible with low viral load.
References: CDC Guidelines, 2023; Journal of Clinical Microbiology, Green KY, 2022.
